280 related articles for article (PubMed ID: 23861462)
1. Variants in SULT2A1 affect the DHEA sulphate to DHEA ratio in patients with polycystic ovary syndrome but not the hyperandrogenic phenotype.
Louwers YV; de Jong FH; van Herwaarden NA; Stolk L; Fauser BC; Uitterlinden AG; Laven JS
J Clin Endocrinol Metab; 2013 Sep; 98(9):3848-55. PubMed ID: 23861462
[TBL] [Abstract][Full Text] [Related]
2. Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome.
Goodarzi MO; Antoine HJ; Azziz R
J Clin Endocrinol Metab; 2007 Jul; 92(7):2659-64. PubMed ID: 17426092
[TBL] [Abstract][Full Text] [Related]
3. Inactivating PAPSS2 mutations in a patient with premature pubarche.
Noordam C; Dhir V; McNelis JC; Schlereth F; Hanley NA; Krone N; Smeitink JA; Smeets R; Sweep FC; Claahsen-van der Grinten HL; Arlt W
N Engl J Med; 2009 May; 360(22):2310-8. PubMed ID: 19474428
[TBL] [Abstract][Full Text] [Related]
4. A SULT2A1 genetic variant identified by GWAS as associated with low serum DHEAS does not impact on the actual DHEA/DHEAS ratio.
Haring R; Wallaschofski H; Teumer A; Kroemer H; Taylor AE; Shackleton CH; Nauck M; Völker U; Homuth G; Arlt W
J Mol Endocrinol; 2013 Feb; 50(1):73-7. PubMed ID: 23132913
[TBL] [Abstract][Full Text] [Related]
5. Human DHEA sulfation requires direct interaction between PAPS synthase 2 and DHEA sulfotransferase SULT2A1.
Mueller JW; Idkowiak J; Gesteira TF; Vallet C; Hardman R; van den Boom J; Dhir V; Knauer SK; Rosta E; Arlt W
J Biol Chem; 2018 Jun; 293(25):9724-9735. PubMed ID: 29743239
[TBL] [Abstract][Full Text] [Related]
6. PAPSS2 deficiency causes androgen excess via impaired DHEA sulfation--in vitro and in vivo studies in a family harboring two novel PAPSS2 mutations.
Oostdijk W; Idkowiak J; Mueller JW; House PJ; Taylor AE; O'Reilly MW; Hughes BA; de Vries MC; Kant SG; Santen GW; Verkerk AJ; Uitterlinden AG; Wit JM; Losekoot M; Arlt W
J Clin Endocrinol Metab; 2015 Apr; 100(4):E672-80. PubMed ID: 25594860
[TBL] [Abstract][Full Text] [Related]
7. Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response.
Kim MS; Shigenaga J; Moser A; Grunfeld C; Feingold KR
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E731-8. PubMed ID: 15198932
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study.
Sathyapalan T; Smith KA; Coady AM; Kilpatrick ES; Atkin SL
Ann Clin Biochem; 2012 Jan; 49(Pt 1):80-5. PubMed ID: 21972424
[TBL] [Abstract][Full Text] [Related]
9. DHEA, DHEAS and PCOS.
Goodarzi MO; Carmina E; Azziz R
J Steroid Biochem Mol Biol; 2015 Jan; 145():213-25. PubMed ID: 25008465
[TBL] [Abstract][Full Text] [Related]
10. Relationship between polymorphisms in the sulfotransferase SULT2A1 gene and dehydroepiandrosterone sulfate concentration in children.
García-Anguita A; Ortega L; Garcés C
Exp Biol Med (Maywood); 2013 Feb; 238(2):163-6. PubMed ID: 23436881
[TBL] [Abstract][Full Text] [Related]
11. Low DHEAS Concentration in a Girl Presenting with Short Stature and Premature Pubarche: A Novel PAPSS2 Gene Mutation.
Eltan M; Yavas Abali Z; Arslan Ates E; Kirkgoz T; Kaygusuz SB; Türkyılmaz A; Bereket A; Turan S; Guran T
Horm Res Paediatr; 2019; 92(4):262-268. PubMed ID: 31461705
[TBL] [Abstract][Full Text] [Related]
12. Trp28Arg/Ile35Thr LHB gene variants are associated with elevated testosterone levels in women with polycystic ovary syndrome.
Batista MC; Duarte Ede F; Borba MD; Zingler E; Mangussi-Gomes J; dos Santos BT; de Moraes OL; Hayashida SA; Baracat EC; da Rocha Neves Fde A; Maciel GA; Bachega TA; Barra GB; Lofrano-Porto A
Gene; 2014 Oct; 550(1):68-73. PubMed ID: 25111116
[TBL] [Abstract][Full Text] [Related]
13. Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.
Lerchbaum E; Schwetz V; Giuliani A; Pieber TR; Obermayer-Pietsch B
Fertil Steril; 2012 Nov; 98(5):1318-25.e1. PubMed ID: 22835450
[TBL] [Abstract][Full Text] [Related]
14. Steroid sulfatase gene variation and DHEA responsiveness to resistance exercise in MERET.
Riechman SE; Fabian TJ; Kroboth PD; Ferrell RE
Physiol Genomics; 2004 May; 17(3):300-6. PubMed ID: 15152080
[TBL] [Abstract][Full Text] [Related]
15. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of STS gene and SULT2A1 gene and neurosteroid levels in Han Chinese boys with attention-deficit/hyperactivity disorder: an exploratory investigation.
Wang LJ; Chan WC; Chou MC; Chou WJ; Lee MJ; Lee SY; Lin PY; Yang YH; Yen CF
Sci Rep; 2017 Apr; 7():45595. PubMed ID: 28367959
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess.
Witchel SF; Kahsar-Miller M; Aston CE; White C; Azziz R
Fertil Steril; 2005 Feb; 83(2):371-5. PubMed ID: 15705377
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome.
Gambineri A; Vicennati V; Genghini S; Tomassoni F; Pagotto U; Pasquali R; Walker BR
J Clin Endocrinol Metab; 2006 Jun; 91(6):2295-302. PubMed ID: 16551740
[TBL] [Abstract][Full Text] [Related]
19. Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism.
Peral B; San Millán JL; Castello R; Moghetti P; Escobar-Morreale HF
J Clin Endocrinol Metab; 2002 Aug; 87(8):3977-83. PubMed ID: 12161545
[TBL] [Abstract][Full Text] [Related]
20. Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome.
Goodarzi MO; Xu N; Azziz R
J Clin Endocrinol Metab; 2008 Jul; 93(7):2909-12. PubMed ID: 18445661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
